Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
Crossref DOI link: https://doi.org/10.1186/s13223-017-0203-z
Published Online: 2017-07-05
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Aberer, Werner
,
Maurer, Marcus
Bouillet, Laurence
Zanichelli, Andrea
Caballero, Teresa
Longhurst, Hilary J.
Perrin, Amandine
Andresen, Irmgard
Funding for this research was provided by:
Shire International GmbH